The role of reactive oxygen species in methamphetamine self-administration and dopamine release in the nucleus accumbens

Addiction Biology

Volumn 22, Issue 5, 2017, Pages 1304-1315

  Jang, Eun Young ^a,b   Yang, Chae Ha ^b   Hedges, David M ^a   Kim, Soo Phil ^b   Lee, Jun Yeon ^b   Ekins, Tyler G ^a   Garcia, Brandon T ^a   Kim, Hee Young ^b   Nelson, Ashley C ^a   Kim, Nam Jun ^b   Steffensen, Scott C ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b Daegu Haany University   (South Korea)

Author keywords

dopamine (DA); methamphetamine self administration; nucleus accumbens; PBN; reactive oxygen species (ROS); TEMPOL

Indexed keywords

DOPAMINE TRANSPORTER; METHAMPHETAMINE; N TERT BUTYL ALPHA PHENYLNITRONE; REACTIVE OXYGEN METABOLITE; TEMPOL; AMINE OXIDE; ANTIOXIDANT; CENTRAL STIMULANT AGENT; DOPAMINE; NEUROPROTECTIVE AGENT; PHENYL-N-TERT-BUTYLNITRONE; SCAVENGER; SPIN LABEL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; BEHAVIOR CHANGE; BRAIN REGION; CELL COUNT; DOPAMINE RELEASE; DRUG SELF ADMINISTRATION; EVOKED RESPONSE; FOOD INTAKE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; METHAMPHETAMINE DEPENDENCE; MICROGLIA; MOUSE; NERVE CELL; NONHUMAN; NUCLEUS ACCUMBENS; OLIGODENDROGLIA; OXIDATIVE STRESS; PRIORITY JOURNAL; REINFORCEMENT; ANIMAL; DRUG EFFECT; FEEDING BEHAVIOR; METABOLISM; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; ASTROCYTES; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CYCLIC N-OXIDES; DOPAMINE; FEEDING BEHAVIOR; FREE RADICAL SCAVENGERS; LOCOMOTION; MALE; METHAMPHETAMINE; MICROGLIA; NEURONS; NEUROPROTECTIVE AGENTS; NUCLEUS ACCUMBENS; OLIGODENDROGLIA; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SELF ADMINISTRATION; SPIN LABELS;

EID: 84978372335     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/adb.12419     Document Type: Article

References (43)

1. Akiyama K, Kanzaki A, Tsuchida K, Ujike H (1994) Methamphetamine-induced behavioral sensitization and its implications for relapse of schizophrenia. Schizophr Res 12:251–257.
2. Baracz SJ, Everett NA, Cornish JL (2015) The involvement of oxytocin in the subthalamic nucleus on relapse to methamphetamine-seeking behaviour. PLoS One 10:e0136132.
3. Beauvais G, Atwell K, Jayanthi S, Ladenheim B, Cadet JL (2011) Involvement of dopamine receptors in binge methamphetamine-induced activation of endoplasmic reticulum and mitochondrial stress pathways. PLoS One 6:e28946.
4. Bu Q, Lv L, Yan G, Deng P, Wang Y, Zhou J, Yang Y, Li Y, Cen X (2013) NMR-based metabonomic in hippocampus, nucleus accumbens and prefrontal cortex of methamphetamine-sensitized rats. Neurotoxicology 36:17–23.
5. Burrows KB, Gudelsky G, Yamamoto BK (2000) Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration. Eur J Pharmacol 398:11–18.
6. Cho AK (1990) Ice: a new dosage form of an old drug. Science 249:631–634.
7. Eyerman DJ, Yamamoto BK (2007) A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine. J Neurochem 103:1219–1227.
8. Fitzmaurice PS, Tong J, Yazdanpanah M, Liu PP, Kalasinsky KS, Kish SJ (2006) Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine. J Pharmacol Exp Ther 319:703–709.
9. Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR (2007) New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol 47:681–698.
10. Frankel PS, Hoonakker AJ, Danaceau JP, Hanson GR (2007) Mechanism of an exaggerated locomotor response to a low-dose challenge of methamphetamine. Pharmacol Biochem Behav 86:511–515.
11. Gluck MR, Moy LY, Jayatilleke E, Hogan KA, Manzino L, Sonsalla PK (2001) Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment. J Neurochem 79:152–160.
12. Graham DG, Tiffany SM, Bell WR Jr, Gutknecht WF (1978) Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol 14:644–653.
13. Hamamura T, Akiyama K, Akimoto K, Kashihara K, Okumura K, Ujike H, Otsuki S (1991) Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis. Brain Res 546:40–46.
14. Horner KA, Gilbert YE, Cline SD (2011) Widespread increases in malondialdehyde immunoreactivity in dopamine-rich and dopamine-poor regions of rat brain following multiple, high doses of methamphetamine. Front Syst Neurosci 5:27.
15. Jang EY, Ryu YH, Lee BH, Chang SC, Yeo MJ, Kim SH, Folsom RJ, Schilaty ND, Kim KJ, Yang CH, Steffensen SC, Kim HY (2015) Involvement of reactive oxygen species in cocaine-taking behaviors in rats. Addict Biol 20:663–675.
16. Jeon JP, Buono RJ, Han BG, Jang EY, Kim SC, Yang CH, Hwang M (2008) Proteomic and behavioral analysis of response to isoliquiritigenin in brains of acute cocaine treated rats. J Proteome Res 7:5094–5102.
17. Kim HK, Park SK, Zhou JL, Taglialatela G, Chung K, Coggeshall RE, Chung JM (2004) Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain. Pain 111:116–124.
18. Kim D, You B, Jo EK, Han SK, Simon MI, Lee SJ (2010) NADPH oxidase 2-derived reactive oxygen species in spinal cord microglia contribute to peripheral nerve injury-induced neuropathic pain. Proc Natl Acad Sci U S A 107:14851–14856.
19. Kita T, Matsunari Y, Saraya T, Shimada K, O'Hara K, Kubo K, Wagner GC, Nakashima T (2000) Evaluation of the effects of alpha-phenyl-N-tert-butyl nitrone pretreatment on the neurobehavioral effects of methamphetamine. Life Sci 67:1559–1571.
20. Kitanaka N, Kitanaka J, Takemura M (2003) Behavioral sensitization and alteration in monoamine metabolism in mice after single versus repeated methamphetamine administration. Eur J Pharmacol 474:63–70.
21. Kogan FJ, Nichols WK, Gibb JW (1976) Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur J Pharmacol 36:363–371.
22. Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177–184.
23. Kuczenski R, Segal DS, Aizenstein ML (1991) Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J Neurosci 11:2703–2712.
24. Macedo DS, Vasconcelos SM, Andrade-Neto M, Belchior LD, Honorio Junior JE, Goncalves DO, Fonteles MM, Silva MI, Aguiar LM, Viana GS, de Sousa FC (2010) Cocaine-induced status epilepticus and death generate oxidative stress in prefrontal cortex and striatum of mice. Neurochem Int 56:183–187.
25. Maharaj H, Sukhdev Maharaj D, Scheepers M, Mokokong R, Daya S (2005) l-DOPA administration enhances 6-hydroxydopamine generation. Brain Res 1063:180–186.
26. Manczak M, Jung Y, Park BS, Partovi D, Reddy PH (2005) Time-course of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, and cytochrome c in aging. J Neurochem 92:494–504.
27. Miller DK, Oelrichs CE, Sage AS, Sun GY, Simonyi A (2013) Repeated resveratrol treatment attenuates methamphetamine-induced hyperactivity and [3H]dopamine overflow in rodents. Neurosci Lett 554:53–58.
28. Miller DK, Oelrichs CE, Sun GY, Simonyi A (2014) Subchronic apocynin treatment attenuates methamphetamine-induced dopamine release and hyperactivity in rats. Life Sci 98:6–11.
29. Miyazaki I, Asanuma M, Diaz-Corrales FJ, Fukuda M, Kitaichi K, Miyoshi K, Ogawa N (2006) Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone-formation-related molecules. Fed Am Soc Exp Biol 20:571–573.
30. Moszczynska A, Turenne S, Kish SJ (1998) Rat striatal levels of the antioxidant glutathione are decreased following binge administration of methamphetamine. Neurosci Lett 255:49–52.
31. Numa R, Kohen R, Poltyrev T, Yaka R (2008) Tempol diminishes cocaine-induced oxidative damage and attenuates the development and expression of behavioral sensitization. Neuroscience 155:649–658.
32. da-Rosa DD, Valvassori SS, Steckert AV, Arent CO, Ferreira CL, Lopes-Borges J, Varela RB, Mariot E, Dal-Pizzol F, Andersen ML, Quevedo J (2012a) Differences between dextroamphetamine and methamphetamine: behavioral changes and oxidative damage in brain of Wistar rats. J Neural Transm (Vienna) 119:31–38.
33. da-Rosa DD, Valvassori SS, Steckert AV, Ornell F, Ferreira CL, Lopes-Borges J, Varela RB, Dal-Pizzol F, Andersen ML, Quevedo J (2012b) Effects of lithium and valproate on oxidative stress and behavioral changes induced by administration of m-AMPH. Psychiatry Res 198:521–526.
34. Rose ME, Grant JE (2008) Pharmacotherapy for methamphetamine dependence: a review of the pathophysiology of methamphetamine addiction and the theoretical basis and efficacy of pharmacotherapeutic interventions. Ann Clin Psychiatry 20:145–155.
35. Shiba T, Yamato M, Kudo W, Watanabe T, Utsumi H, Yamada K (2011) In vivo imaging of mitochondrial function in methamphetamine-treated rats. Neuroimage 57:866–872.
36. Steffensen SC, Taylor SR, Horton ML, Barber EN, Lyle LT, Stobbs SH, Allison DW (2008) Cocaine disinhibits dopamine neurons in the ventral tegmental area via use-dependent blockade of GABA neuron voltage-sensitive sodium channels. Eur J Neurosci 28:2028–2040.
37. Sun D, Yue Q, Guo W, Li T, Zhang J, Li G, Liu Z, Sun J (2015) Neuroprotection of resveratrol against neurotoxicity induced by methamphetamine in mouse mesencephalic dopaminergic neurons. Biofactors 41:252–260.
38. Turrens JF (2003) Mitochondrial formation of reactive oxygen species. J Physiol 552:335–344.
39. Valvassori SS, Rezin GT, Ferreira CL, Moretti M, Goncalves CL, Cardoso MR, Streck EL, Kapczinski F, Quevedo J (2010) Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine. J Psychiatr Res 44:903–909.
40. Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F (2007) Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol 64:1575–1579.
41. Yorgason JT, Espana RA, Jones SR (2011) Demon voltammetry and analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures. J Neurosci Methods 202:158–164.
42. Yun J (2014) L-tetrahydropalmatine inhibits methamphetamine-induced locomotor activity via regulation of 5-HT neuronal activity and dopamine D3 receptor expression. Phytomedicine 21:1287–1291.
43. Zhao RJ, Koo BS, Kim GW, Jang EY, Lee JR, Kim MR, Kim SC, Kwon YK, Kim KJ, Huh TL, Kim DH, Shim I, Yang CH (2005) The essential oil from Angelica gigas NAKAI suppresses nicotine sensitization. Biol Pharm Bull 28:2323–2326.